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Miguel N. Burnier aAbstractPurpose: The aim of this study was to determine the frequency of clinically unsuspected ocular surface squamous neoplasia (OSSN)
in cases of biopsied pterygium (PT).
Methods: We reviewed 15,016 cases presented at the Henry C. Witelson Ocular Pathology Laboratory during the period 1993–
2013. All cases with a clinical diagnosis of PT were included. Histopathological diagnoses were reviewed and demographic data
were retrieved from histopathological request forms. All cases associated with OSSN were re-evaluated independently by two
ocular pathologists. The classification of OSSN in PT cases was made based on the Armed Forces Institute of Pathology (AFIP)
recommendations.
Results: Two hundred and fifteen cases were diagnosed clinically as PT (1.43%) and 54% were from male patients. The average age
at diagnosis was 53.4 ± 15.5 years. OSSN was identified in five cases (2.33%), and four of these cases were from female patients
(80%). The average age of patients with PT and OSSN was similar to PT patients without OSSN (P > 0.05). Cases with OSSN were
diagnosed as conjunctival intraepithelial neoplasia (CIN) I (60%), CIN II (20%), and CIN III (20%). There was complete agreement
between the two pathologists (100%).
Conclusions: The relatively high rate of dysplasia in a low ultraviolet light index area challenges the main cause of this disease in
our population, a hypothesis that should be evaluated in future studies. We suggest that all PT samples should be sent for
histopathological evaluation even in areas with low ultraviolet light index.
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Pterygium (PT) is a common conjunctival lesion of
unknown etiology that can cause ocular irritation, visualdisturbances, and most often cosmetic issues. Clinically, PT
manifests as a wing-shaped fleshy growth, usually occurring
on the nasal conjunctiva and cornea, growing toward the
center of the cornea. Histologically, it shows elastotice:
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114 P. Zoroquiain et al.degeneration of the substantia propria.1 The main risk factor
for the development of this lesion has been found to be ultra-
violet (UV) light exposure.2 This association is supported by
the higher prevalence of PT in regions with high UV expo-
sure, notably regions closer to the equator.3,4
Ocular surface squamous neoplasia (OSSN) represents a
broad spectrum of corneal and conjunctival epithelial neo-
plasias that range from dysplasia (conjunctival intraepithelial
neoplasia [CIN] I, II, and III or mild, moderate or severe dys-
plasia respectively) to invasive squamous cell carcinoma
(SCC).5 OSSN shares some risk factors with PT, in particular
exposure to UV radiation. OSSN also varies worldwide with
a prevalence of 1.9% estimated in Australia and age stan-
dardized incidence rates (cases/year/100,000 inhabitants) of
1.38 in Africa and an incidence of 0.05% in Europe.6 Because
OSSN and pterygium share the same risk factors, they are
believed to coexist and may even be related.7,8
The relationship between both entities has been previ-
ously described in the literature. The prevalence of OSSN in
PT is 9.8% in Brisbane, Australia8 and 5% in Sydney,
Australia.7 In Florida, the prevalence is 1.7%,3 while it is 0%
in Toronto, Canada.9 The different UV indices in various loca-
tions around the world are shown in Table 1. In addition,
some case reports have shown that pterygium can masquer-
ade as a wider array of epithelial neoplasia and even some
hematological malignancies.10
The purpose of this study was to determine the frequency
of OSSN in PT specimens in a low UV area, mainly Montreal,
Quebec, Canada.Methods
All specimens received between 1993 and 2013 at the
Henry C. Witelson Ocular Pathology Laboratory (McGill
University, Montreal, Canada) were reviewed. All cases with
a clinical diagnosis of PT were included in the study. The final
pathological diagnosis and clinical information, including age
and gender, were obtained. Squamous lesions were classi-
fied pathologically according to the Armed Forces Institute
of Pathology (AFIP) as PT, or CIN I, II, or III. All cases with dys-
plastic changes were reviewed independently by two pathol-
ogists. All data accumulation was in accordance with Canada
and the Province of Quebec legislation and adhered to the
tenets of the Declaration of Helsinki.Data management and statistical analysis
Data are presented as percentages and means ± standard
deviation (SD). The Student’s t-test was used to compare the
average age at presentation of PT with and without OSSN.
The association between gender and OSSN in PT was ana-
lyzed using Fisher exact test and odds ratio (OR) with 95%
confidence intervals (Cis). Differences were considered
significant when P < 0.05. Statistics were performed usingTable 1. Average UV index in different locations around the world. Modified
index3.html].
Country (City) . J F M A
Australia (Darwin) 13S 12 13 12 10
Canada (Vancouver) 49N 1 1 3 4
USA (Los Angeles) 34N 3 4 6 8Microsoft Excel (Microsoft, Redmond, WA, USA) and
GraphPad Prism 5.0 software (San Diego, CA, USA).Results
Of 15,016 cases presented to the Henry C. Witelson Ocular
Pathology Laboratory during the period of 1993–2013, 215
(1.43%) PT cases were collected. Most of these cases (54%)
were from male patients. The average age at diagnosis was
53.4 ± 15.5 years.
The frequency of epithelial neoplasia in PT cases was
2.33% (n = 5), of which four of the five cases were from
female patients (80%). The average age at presentation of
those cases was 59.2 ± 14.75. The average age of patients
presenting with PT without neoplasia was 53.4 ± 15.5.
Dysplastic changes in PT cases were CIN I (60%, Fig. 1A),
CIN II (20%, Fig. 1B), and CIN III (20%, Fig. 1C). The average
age of the patients presenting with PT with dysplasia did not
significantly differ from patients with PT without dysplasia
(P = 0.87). Similarly, there was no association between gen-
der and OSSN in PT (P = 0.18).Discussion
In this study, the frequency of OSSN within surgically
excised PT was higher than expected (2.33%). This might
be explained by the fact that PT is excised primarily when
they cause visual problems by either being in close proximity
to the visual axis or by inducing astigmatism, having a suspi-
cious appearance and growth, or due to symptoms of irrita-
tion or cosmetic disturbances.11 As a result, cases with
suspicious appearance will be sent for histological examina-
tion while benign looking cases will be simply discarded.
We strongly believe that the dysplastic findings (CIN) in PT
cases emphasize the notion that every sample should be sent
for microscopic analysis, because these patients need closer
follow-up based on the fact that 10–24% of them will have
OSSN recurrences within the next 15 years.12
Having a relatively high number of OSSN in cases of PT is
unexpected in our area since Montreal has a relatively low
yearly UV exposure (similar to the latitude of Vancouver)
(Table 1). Our frequency rates were close to rates reported
in Sydney and even higher than in Florida3, regions that are
known to have higher yearly exposures to UV rays than
Montreal. This could be partly explained by the fact that
snow and snowfall persist late into spring in Montreal.
Furthermore, it has been reported that UV rays reflected
off snow plays a greater role in tissue damage13 with the
addition that snowflakes have the highest UV reflectance.
While these mechanisms have been postulated to cause
corneal disease, such as photokeratitis and climatic droplet
keratopathy,14 to the best of our knowledge, no strong
evidence has demonstrated a relation with PT. Moreover,
these results might also be explained by the high ethnicfrom: [http://www.who.int/uv/intersunprogramme/activities/uv_index/en/
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Figure 1. Representative examples of PT with OSSN. (a) Pterygium with CIN I (mild dysplasia). Large arrow shows large and irregular nuclei. Smaller
arrow shows loss of polarity of the basal cells. (b) Pterygium with CIN II (moderate dysplasia). The dysplastic cells occupy two thirds of the epithelial
thickness, showing maturation in the higher stratum (arrow). (c) Pterygium with CIN III (severe dysplasia). The dysplastic cells occupy the full thickness of
the epithelium. Arrow head shows atypical mitotic figure in the upper part of the epithelium. Shorter arrow shows elastotic degeneration. (d) Average
age of pterigyum with and without dysplasia.
Table 2. Cases of pterygia associated with OSSN in our cohort.
Case
number
Gender Age at
biopsy
Degree of
dysplasia
Follow-up
1 F 58 CIN I No recurrence after
6 years f/u
2 F 78 CIN I Lost f/u
3 F 59 CIN II Lost f/u
4 F 64 CIN III No recurrence after
2.5 years f/u
5 M 37 CIN I Lost f/u
OSSN: Ocular surface squamous neoplasia; M: Male; F: Female; CIN: Conjunctival
intraepithelial neoplasia; f/u: follow-up.
High frequency of squamous neoplasia in pterygium in a low UV area 115heterogeneity of the population in the Montreal region,
including immigrants who come from countries near the
equator. Unfortunately, however, this information is not avail-
able in medical charts. Also, it is important to highlight that
although our institution is a referral center in ophthalmic
pathology, none of the cases in this series was a referral,
emphasizing the actual representation of our cases from
our area.
Analysis of the demographic data showed that there was
no significant difference in the average age of patients with
PT associated with epithelial neoplasia and patients having
PT without epithelial neoplasia (P = 0.87). Furthermore, the
average age of dysplastic PT cases was even lower than those
found in previous studies.15 Hence, age does not seem to be
a significant demographic risk factor for the development of
OSSN in PT cases in our study. Thus, PT samples in younger
patients should also be sent for pathological evaluation. In
addition, OSSN associated with PT was found to be more fre-
quent in females than males (80% vs. 20%), which goes
against a previous studies showing a higher prevalence of
OSSN in men.15 These results are intriguing since most outer
occupational activities are traditionally undertaken by males.
This further brings into question the hypothesis that UV radi-
ation is the main risk factor for OSSN development in our
population, although our sample size is too small to come
up with any definitive conclusions.
Most epithelial lesions associated with PT were CIN I
(60%). This assumes progressive damage by the main risk fac-
tor of the region (UV or other) that has caused the progres-
sion to CIN I (mild dysplasia). To avoid overestimating CIN I
lesions, all cases were reviewed by two pathologists and
100% concordance was found. All patients with OSSN should
be followed on a regular basis to screen for the occurrence of
new lesions in the conjunctiva because these patients already
have enough risk factors for developing new OSSN in the
currently uninvolved conjunctiva. In addition, we argue thatall PT samples should be sent to pathology since PT and
OSSN share similar risk factors, and therefore can co-exist.7,8
Interestingly, most OSSN in the present study was found
to be CIN I, as in Florida, while the most common neoplasia
was CIN II in Australia. This might be explained by the strict
and thorough evaluation of such lesions in North America
where the lesions are removed before they develop into a
CIN II or it might be explained in part by the higher UV expo-
sure in Australia, which might lead to more rapid lesion
progression.
The treatment options for cases of PT are controversial.
One of the main problems encountered after surgical exci-
sion alone is the high recurrence rate which can reach up to
89%.16 All the cases of PT with OSSN in this cohort are pri-
mary cases from different patients and none of them is a
recurrence. Table 2 shows the characteristics of each individ-
ual case with the follow-up.
Our study is not without limitations. For instance, it is
important to highlight that our study is retrospective, and
thus considers only biopsied lesions and may not represent
the actual frequency of OSSN in PT in our region. However,
our study shares this bias with similar studies from around
116 P. Zoroquiain et al.the globe, and thus presents meaningful data. The relatively
small number of cases in this series can be attributed to the
lower incidence of PT in this area compared to other high risk
areas6 and the possibility that some excised lesions are not
sent to histopathological examination; however, the real inci-
dence of OSSN in PT in this part of the world has not been
well studied to date.
In conclusion, this study showed an unexpectedly rela-
tively high frequency of OSSN in PT cases in a city where
UV exposure is low. Moreover, age did not seem to be a sig-
nificant risk factor to develop OSSN in cases of PT and most
of these patients were female. We therefore highly suggest
that all PT specimens that are surgically excised, regardless
of the age and sex of the patient, should be sent for patho-
logical evaluation. In addition, if an OSSN is found, the
patient requires closer follow-up for screening of new lesions.Conflict of interest
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